Treat Canine Osteoarthritis (OA) the Galliprant® (grapiprant tablets) Way

Treat canine osteoarthritis (OA) pain and inflammation with confidence at every stage of OA and help dogs get back to being active members of their families.

1a-two-men-w-three-dogs-Gal-750 x 562

Helping Dogs Lead Healthy, Active Lives

Too many dogs are suffering in silence due to unrecognized or untreated canine osteoarthritis (OA). To provide the highest quality of care, it’s time to evolve the approach to recognizing, diagnosing and managing canine OA through early intervention and treatment.

  • Progressive

    Canine OA is a progressive disease, and signs of pain may be subtle or overlooked

  • Conformational

    Canine OA is often conformational in nature and can affect young dogs, so early detection and diagnosis is key1

  • Multimodal

    Start multimodal treatment of OA as soon as the dog is diagnosed

Canine OA is the most common cause of chronic pain in dogs, affecting 1 in 5 adult dogs in the US.2

3a-5-dog-infographic-Gal-929 x 117

Early signs of OA can be hard to distinguish, leading to delayed diagnosis and chronic pain later in life.

The Condition

7a-woman-holding-dog-Gal-727 x 417

Canine OA, the most common cause of chronic pain in dogs2, is often conformational in nature so can develop at a young age.1

Learn about the Condition

Stages & Etiology

7b-two-dogs-with-toy-Gal-727 x 417

Canine OA is a progressive disease that can affect dogs during any stage of life, limiting their ability to fully engage with day-to-day activities.

Learn about the Stages

Symptoms and Diagnosis

7c-vet-inspecting-dog-Gal-727 x 417

Recognizing the signs of OA and engaging the pet owner throughout the process will help you diagnose accurately and early, so you can provide high quality care to your patients.

Learn about the Signs


7d-hands-pouring-meds-Gal-727 x 417

A multimodal treatment approach begins with pain management.

Treating Canine OA

Watch Inspiring Stories

7f-owner-and-dog-on-vet-table-Gal-727 x 417

Many veterinarians are fulfilling their purpose through effective pain relief for canine OA.

Watch Inspiring Stories


Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.

Important Safety Information

Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.

Contact your Elanco or distributor representative, or call Elanco (1-888-545-5973) to discover how you can incorporate Galliprant into your canine OA protocol today.

Connect with Galliprant

Let’s keep in touch

Elanco, Galliprant and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2020 Elanco. PM-US-19-1926